The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Small cell lung cancer: Where do we go from here?
Open accessAbstract
Small cell lung cancer (SCLC) is an aggressive disease that accounts for approximately 14% of all lung cancers. In the United States, approximately 31,000 patients are diagnosed annually with SCLC. Despite numerous clinical trials, including at least 40 phase 3 trials since the 1970s, systemic treatment for patients with SCLC has not changed significantly in the past several decades. Consequently, the 5‐year survival rate remains low at <7% overall, and most patients survive for only 1 year or less after diagnosis. Unlike nonsmall cell lung cancer (NSCLC), in which major advances have been made using targeted therapies, there are still no approved targeted drugs for SCLC. Significant barriers to progress in SCLC include 1) a lack of early detection modalities, 2) limited tumor tissue for translational research (eg, molecular profiling of DNA, RNA, and/or protein alterations) because of small diagnostic biopsies and the rare use of surgical resection in standard treatment, and 3) rapid disease progression with poor understanding of the mechanisms contributing to therapeutic resistance. In this report, the authors review the current state of SCLC treatment, recent advances in current understanding of the underlying disease biology, and opportunities to advance translational research and therapeutic approaches for patients with SCLC. Cancer 2015;121:664–672. © 2014 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
Aupérin, A., Arriagada, R., Pignon, J.-P., Le Péchoux, C., Gregor, A., Stephens, R. J., Kristjansen, P. E. G., Johnson, B. E., Ueoka, H., Wagner, H., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410703 · Cited by 1,718
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S., & Johnson, D. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400403 · Cited by 1,506
Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Kim, D.-W., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J., Sharma, S., De Pas, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311107 · Cited by 1,495
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Peifer, M., Fernández-Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., Plenker, D., Leenders, F., Sun, R., Zander, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2396 · Cited by 1,397
Noda, K., Nishiwaki, Y., Kawahara, M., Negoro, S., Sugiura, T., Yokoyama, A., Fukuoka, M., Mori, K., Watanabe, K., Tamura, T., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003034 · Cited by 1,371
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
Slotman, B., Faivre-Finn, C., Kramer, G., Rankin, E., Snee, M., Hatton, M., Postmus, P., Collette, L., Musat, E., & Senan, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071780 · Cited by 1,133
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,110
Rudin, C. M., Durinck, S., Stawiski, E. W., Poirier, J. T., Modrusan, Z., Shames, D. S., Bergbower, E. A., Guan, Y., Shin, J., Guillory, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2405 · Cited by 1,077
Self-citationThe BATTLE Trial: Personalizing Therapy for Lung Cancer
Kim, E. S., Herbst, R. S., Wistuba, I. I., Lee, J. J., Blumenschein, G. R., Tsao, A., Stewart, D. J., Hicks, M. E., Erasmus, J., Gupta, S., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0010 · Cited by 889
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Hodgkinson, C. L., Morrow, C. J., Li, Y., Metcalf, R. L., Rothwell, D. G., Trapani, F., Polanski, R., Burt, D. J., Simpson, K. L., Morris, K., et al. (2014) · Nature Medicine · doi:10.1038/nm.3600 · Cited by 694
Hanna, N., Bunn, P. A., Langer, C., Einhorn, L., Guthrie, T., Beck, T., Ansari, R., Ellis, P., Byrne, M., Morrison, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8595 · Cited by 681
Meuwissen, R., Linn, S. C., Linnoila, R. I., Zevenhoven, J., Mooi, W. J., & Berns, A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00220-4 · Cited by 643
Reck, M., Bondarenko, I., Luft, A., Serwatowski, P., Barlesi, F., Chacko, R., Sebastian, M., Lu, H., Cuillerot, J.-M., & Lynch, T. J. (2013) · Annals of Oncology · doi:10.1093/annonc/mds213 · Cited by 611
Byers, L. A., Wang, J., Nilsson, M. B., Fujimoto, J., Saintigny, P., Yordy, J., Giri, U., Peyton, M., Fan, Y. H., Diao, L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0112 · Cited by 557
Self-citationResults of the Two Incidence Screenings in the National Lung Screening Trial
Aberle, D. R., DeMello, S., Berg, C. D., Black, W. C., Brewer, B., Church, T. R., Clingan, K. L., Duan, F., Fagerstrom, R. M., Gareen, I. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208962 · Cited by 550
Lara, P. N., Natale, R., Crowley, J., Lenz, H. J., Redman, M. W., Carleton, J. E., Jett, J., Langer, C. J., Kuebler, J. P., Dakhil, S. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1061 · Cited by 525
Daniel, V. C., Marchionni, L., Hierman, J. S., Rhodes, J. T., Devereux, W. L., Rudin, C. M., Yung, R., Parmigiani, G., Dorsch, M., Peacock, C. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4210 · Cited by 467
Self-citationMolecular genetics of small cell lung carcinoma
WISTUBA, I. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90072-7 · Cited by 421
The Aurora kinase family in cell division and cancer
Vader, G., & Lens, S. M. A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.07.003 · Cited by 417
Wistuba, I. I., Behrens, C., Virmani, A. K., Mele, G. M., Milchgrub, S., Girard, L., Fondon, J. W., Garner, H. R., McKay, B., Latif, F., et al. (2000) · PubMed · Cited by 405
Fried, D. B., Morris, D. E., Poole, C., Rosenman, J. G., Halle, J. S., Detterbeck, F. C., Hensing, T. A., & Socinski, M. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.178 · Cited by 391
Jahchan, N. S., Dudley, J. T., Mazur, P. K., Flores, N., Yang, D., Palmerton, A., Zmoos, A.-F., Vaka, D., Tran, K. Q. T., Zhou, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0183 · Cited by 358
Ruysscher, D. D., Pijls-Johannesma, M. C. G., Bentzen, S. M., Minken, A., Wanders, R., Lutgens, L. C. H. W., Hochstenbag, M. M. H., Boersma, L. J., Wouters, B. G., Lammering, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9793 · Cited by 337
Brockmann, M., Poon, E., Berry, T., Carstensen, A., Deubzer, H. E., Rycak, L., Jamin, Y., Thway, K., Robinson, S. P., Roels, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.005 · Cited by 299
Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma
Schaffer, B. E., Park, K.-S., Yiu, G., Conklin, J. F., Lin, C., Burkhart, D. L., Karnezis, A. N., Sweet-Cordero, E. A., & Sage, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4228 · Cited by 253
den Hollander, J., Rimpi, S., Doherty, J. R., Rudelius, M., Buck, A., Hoellein, A., Kremer, M., Graf, N., Scheerer, M., Hall, M. A., et al. (2010) · Blood · doi:10.1182/blood-2009-11-251074 · Cited by 242
Jones, M. H., Virtanen, C., Honjoh, D., Miyoshi, T., Satoh, Y., Okumura, S., Nakagawa, K., Nomura, H., & Ishikawa, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15693-6 · Cited by 241
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
Demedts, I. K., Vermaelen, K. Y., & van Meerbeeck, J. P. (2010) · European Respiratory Journal · doi:10.1183/09031936.00105009 · Cited by 216
Socinski, M. A., Smit, E. F., Lorigan, P., Konduri, K., Reck, M., Szczesna, A., Blakely, J., Serwatowski, P., Karaseva, N. A., Ciuleanu, T., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1548 · Cited by 211
High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90526-4 · Cited by 207
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90119-5 · Cited by 196
Pietanza, M. C., Kadota, K., Huberman, K., Sima, C. S., Fiore, J. J., Sumner, D. K., Travis, W. D., Heguy, A., Ginsberg, M. S., Holodny, A. I., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2059 · Cited by 188
De Ruysscher, D., Pijls-Johannesma, M., Vansteenkiste, J., Kester, A., Rutten, I., & Lambin, P. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj094 · Cited by 184
A framework for identification of actionable cancer genome dependencies in small cell lung cancer
Sos, M. L., Dietlein, F., Peifer, M., Schöttle, J., Balke-Want, H., Müller, C., Koker, M., Richters, A., Heynck, S., Malchers, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207310109 · Cited by 179
Cardnell, R. J., Feng, Y., Diao, L., Fan, Y.-H., Masrorpour, F., Wang, J., Shen, Y., Mills, G. B., Minna, J. D., Heymach, J. V., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1975 · Cited by 178
Self-citationp53 mutations in human lung tumors.
Cw, M., Simon, K., Aslo, A., Kok, K., Yokota, J., Buys, C. H. C. M., Terada, M., & Koeffler, H. P. (1992) · PubMed · Cited by 174
Rudin, C. M., Salgia, R., Wang, X., Hodgson, L. D., Masters, G. A., Green, M., & Vokes, E. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3461 · Cited by 166
Self-citationCardnell, R. J. G., & Byers, L. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3391 · Cited by 165
Self-citationKaye, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205834 · Cited by 153
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein
Krug, L. M., Crapanzano, J. P., Azzoli, C. G., Miller, V. A., Rizvi, N. A., Gomez, J. E., Kris, M. G., Pizzo, B., Tyson, L. B., Dunne, M., et al. (2005) · Cancer · doi:10.1002/cncr.21000 · Cited by 153
Dy, G. K., Miller, A. A., Mandrekar, S. J., Aubry, M. C., Langdon, R. M., Morton, R. F., Schild, S. E., Jett, J. R., & Adjei, A. A. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi365 · Cited by 151
Zatloukal, P., Cardenal, F., Szczęsna, A., Горбунова, В. А., Moiseyenko, V. M., Zhang, X., Cisar, L. A., Soria, J., Dómine, M., & Thomas, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq036 · Cited by 149
Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes
Varghese, A. M., Zakowski, M. F., Yu, H. A., Won, H. H., Riely, G. J., Krug, L. M., Kris, M. G., Rekhtman, N., Ladanyi, M., Wang, L., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000142 · Cited by 141
Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma
Helin, K., Holm, K., Niebuhr, A., Eiberg, H., Tommerup, N., Hougaard, S., Poulsen, H. S., Spang‐Thomsen, M., & Nørgaard, P. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6933 · Cited by 131
Aurora A Is Essential for Early Embryonic Development and Tumor Suppression
Lu, L., Wood, J. L., Ye, L., Minter‐Dykhouse, K., Saunders, T. L., Yu, X., & Chen, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805880200 · Cited by 111
Huncharek, M. S., & McGarry, R. C. (2004) · The Oncologist · doi:10.1634/theoncologist.9-6-665 · Cited by 101
Hook, K. E., Garza, S. J., Lira, M. E., Ching, K. A., Lee, N. V., Cao, J. Q., Yuan, J. T., Ye, J., Ozeck, M., Shi, S. T., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0184 · Cited by 98
Mok, T. S. K., Kim, D., Wu, Y.-L. L. C., Solomon, B., Nakagawa, K., Mekhail, T. M., Felip, E., Cappuzzo, F., Paolini, J., Usari, T., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.8002 · Cited by 84
Spigel, D. R., & Socinski, M. A. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318286cf88 · Cited by 74
Tamborini, E., Bonadiman, L., Negri, T., Greco, A., Staurengo, S., Bidoli, P., Pastorino, U., Pierotti, M. A., & Pilotti, S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1013 · Cited by 67
Third-Line Chemotherapy in Small-Cell Lung Cancer: An International Analysis
Simos, D., Sajjady, G., Sergi, M., Liew, M. S., Califano, R., Ho, C., Leighl, N. B., White, S. C., Summers, Y., Petrcich, W., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.11.003 · Cited by 61
Progress in the management of limited‐stage small cell lung cancer
Amini, A., Byers, L. A., Welsh, J. W., & Komaki, R. U. (2013) · Cancer · doi:10.1002/cncr.28505 · Cited by 60
Self-citationPeng, W., Shibata, T., Katoh, H., Kokubu, A., Matsuno, Y., Asamura, H., Tsuchiya, R., Kanai, Y., Hosoda, F., Sakiyama, T., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00092.x · Cited by 55
Teaching an Old Dog New Tricks: Drug Repositioning in Small Cell Lung Cancer
Wang, J., & Byers, L. A. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0790 · Cited by 21
Self-citationPerspective: Opportunities in recalcitrant, rare and neglected tumors
Teicher, B. A. (2013) · Oncology Reports · doi:10.3892/or.2013.2581 · Cited by 11
Cited by
Paz-Ares, L., Dvorkin, M., Chen, Y., Reinmuth, N., Hotta, K., Trukhin, D., Statsenko, G., Hochmair, M. J., Özgüroğlu, M., Ji, J. H., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32222-6 · Cited by 2,298
Antonia, S. J., López-Martin, J. A., Bendell, J., Ott, P. A., Taylor, M., Eder, J. P., Jäger, D., Pietanza, M. C., Le, D. T., de Braud, F., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30098-5 · Cited by 1,244
Gay, C. M., Stewart, C. A., Park, E. M., Diao, L., Groves, S. M., Heeke, S., Nabet, B. Y., Fujimoto, J., Solis, L. M., Lu, W., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.014 · Cited by 962
Self-citationHellmann, M. D., Callahan, M. K., Awad, M. M., Calvo, E., Ascierto, P. A., Atmaca, A., Rizvi, N. A., Hirsch, F. R., Selvaggi, G., Szustakowski, J. D., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.001 · Cited by 893
Goldman, J. W., Dvorkin, M., Chen, Y., Reinmuth, N., Hotta, K., Trukhin, D., Statsenko, G., Hochmair, M. J., Özgüroğlu, M., Ji, J. H., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30539-8 · Cited by 688
Metadata
- Authors
- Byers, L. A., & Rudin, C. M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2014-10-21
- Volume
- 121
- Issue
- 5
- Pages
- 664-672
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1547463098
- Cited by
- 636
- References
- 60
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.